Baseline characteristics of the head-to-head studies comparing ranibizumab with bevacizumab.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
CATT = The Comparison of Age-related macular degeneration Treatments Trials; IVAN = The Alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularization study; MANTA = The Multicenter Anti-VEGF Trial; GEFAL = The Groupe d'Etude Français Avastin versus Lucentis dans la DMLA néovasculaire (The French Study Group Avastin versus Lucentis for neovascular AMD). Baseline characteristics of the head-to-head studies comparing ranibizumab with bevacizumab.
创建时间：
2014-10-16
